Consulting Report / Office of Health Economics
Citation Profile [Updated: 2024-03-05 07:42:34]
5 Years H Index
4
Impact Factor (IF)
0.11
5 Years IF
0.17
Data available in this
report
[Raw
data] [50 most cited papers]
[50 most relevant papers]
[cites used to compute IF]
[Recent
citations ][Frequent citing
series ] [more data in
EconPapers]
[
trace new citations] [Missing
citations? Add them now]
[Incorrect content? Let us
know]
Main indicators
Raw Data
| IF | AIF | CIF | IF5 | DOC | CDO | CIT | NCI | CCU | D2Y | C2Y | D5Y | C5Y | SC | %SC | CiY | II | AII | |
| 2005 | 0 | 0.6 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.37 | |||||
| 2006 | 0 | 0.59 | 0 | 0 | 1 | 2 | 0 | 0 | 1 | 1 | 0 | 0 | 0.34 | |||||
| 2008 | 0 | 0.59 | 0 | 0 | 1 | 3 | 3 | 0 | 1 | 2 | 0 | 0 | 0.29 | |||||
| 2009 | 0 | 0.59 | 0 | 0 | 2 | 5 | 0 | 0 | 1 | 3 | 0 | 0 | 0.33 | |||||
| 2010 | 0.33 | 0.53 | 0.11 | 0.2 | 4 | 9 | 0 | 1 | 1 | 3 | 1 | 5 | 1 | 0 | 0 | 0.3 | ||
| 2011 | 0 | 0.61 | 0 | 0 | 3 | 12 | 5 | 1 | 6 | 8 | 0 | 0 | 0.37 | |||||
| 2012 | 0 | 0.68 | 0 | 0 | 3 | 15 | 6 | 1 | 7 | 10 | 0 | 0 | 0.36 | |||||
| 2014 | 0 | 0.67 | 0.11 | 0.08 | 3 | 18 | 9 | 2 | 4 | 3 | 12 | 1 | 0 | 1 | 0.33 | 0.34 | ||
| 2015 | 1 | 0.66 | 0.3 | 0.46 | 5 | 23 | 5 | 7 | 11 | 3 | 3 | 13 | 6 | 1 | 14.3 | 1 | 0.2 | 0.36 |
| 2016 | 0 | 0.65 | 0.04 | 0.07 | 4 | 27 | 1 | 1 | 12 | 8 | 14 | 1 | 0 | 0 | 0.35 | |||
| 2017 | 0.11 | 0.62 | 0.18 | 0.13 | 7 | 34 | 5 | 6 | 18 | 9 | 1 | 15 | 2 | 2 | 33.3 | 1 | 0.14 | 0.35 |
| 2018 | 0.18 | 0.61 | 0.21 | 0.37 | 9 | 43 | 12 | 9 | 27 | 11 | 2 | 19 | 7 | 1 | 11.1 | 2 | 0.22 | 0.35 |
| 2019 | 0.25 | 0.63 | 0.2 | 0.18 | 3 | 46 | 0 | 8 | 36 | 16 | 4 | 28 | 5 | 2 | 25 | 0 | 0.36 | |
| 2020 | 0.25 | 0.71 | 0.16 | 0.14 | 12 | 58 | 16 | 9 | 45 | 12 | 3 | 28 | 4 | 0 | 1 | 0.08 | 0.76 | |
| 2021 | 0.33 | 0.98 | 0.11 | 0.17 | 12 | 70 | 1 | 8 | 53 | 15 | 5 | 35 | 6 | 1 | 12.5 | 0 | 0.4 | |
| 2022 | 0.25 | 0.76 | 0.16 | 0.21 | 6 | 76 | 0 | 12 | 65 | 24 | 6 | 43 | 9 | 0 | 0 | 0.24 |
| IF: | Two years Impact Factor: C2Y / D2Y |
| AIF: | Average Impact Factor for all series in RePEc in year y |
| CIF: | Cumulative impact factor |
| IF5: | Five years Impact Factor: C5Y / D5Y |
| DOC: | Number of documents published in year y |
| CDO: | Cumulative number of documents published until year y |
| CIT: | Number of citations to papers published in year y |
| NCI: | Number of citations in year y |
| CCU: | Cumulative number of citations to papers published until year y |
| D2Y: | Number of articles published in y-1 plus y-2 |
| C2Y: | Cites in y to articles published in y-1 plus y-2 |
| D5Y: | Number of articles published in y-1 until y-5 |
| C5Y: | Cites in y to articles published in y-1 until y-5 |
| SC: | selft citations in y to articles published in y-1 plus y-2 |
| %SC: | Percentage of selft citations in y to articles published in y-1 plus y-2 |
| CiY: | Cites in year y to documents published in year y |
| II: | Immediacy Index: CiY / Documents. |
| AII: | Average Immediacy Index for series in RePEc in year y |
50 most cited documents in this series
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2012 | The Many Faces of Innovation. (2012). Sussex, J ; Mordoh, A ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000154. Full description at Econpapers || Download paper | 7 |
| 2 | 2018 | The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009. Full description at Econpapers || Download paper | 7 |
| 3 | 2011 | The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192. Full description at Econpapers || Download paper | 6 |
| 4 | 2014 | The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:000050. Full description at Econpapers || Download paper | 5 |
| 5 | 2020 | International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making. (2020). Zhang, Kyann ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:002271. Full description at Econpapers || Download paper | 4 |
| 6 | 2008 | Medical Research: Whats It Worth?. (2008). Europe, Rand ; Of, Office . In: Consulting Reports. RePEc:ohe:conrep:000236. Full description at Econpapers || Download paper | 4 |
| 7 | 2015 | Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576. Full description at Econpapers || Download paper | 3 |
| 8 | 2014 | The Trajectory of Dementia in the UK - Making a Difference. (2014). O'Neill, Phill ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cockcroft, L ; Sussex, J ; Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:000518. Full description at Econpapers || Download paper | 3 |
| 9 | 2020 | Indication-Based Pricing (IBP) Consultation Report. (2020). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002261. Full description at Econpapers || Download paper | 3 |
| 10 | 2020 | A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold. (2020). , Towse ; FERRARO, . In: Consulting Reports. RePEc:ohe:conrep:002284. Full description at Econpapers || Download paper | 3 |
| 11 | 2017 | Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802. Full description at Econpapers || Download paper | 3 |
| 12 | 2020 | Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?. (2020). Zhang, Kyann ; Garau, Martina ; Cubi-Molla, Patricia ; Errea, M. In: Consulting Reports. RePEc:ohe:conrep:002247. Full description at Econpapers || Download paper | 3 |
| 13 | 2018 | Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. (2018). Towse, Adrian ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:001978. Full description at Econpapers || Download paper | 2 |
| 14 | 2014 | Obstructive Sleep Apnoea: Health Economics Report. (2014). Garau, Martina ; Sussex, J ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:001504. Full description at Econpapers || Download paper | 2 |
| 15 | 2018 | Barriers to Uptake of Minimal Access Surgery in the United Kingdom. (2018). Sampson, Christopher ; Lorgelly, Paula ; Cole, Amanda ; O'Neill, P. In: Consulting Reports. RePEc:ohe:conrep:001976. Full description at Econpapers || Download paper | 2 |
| 16 | 2016 | Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. (2016). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Cubi-Molla, Patricia. In: Consulting Reports. RePEc:ohe:conrep:001699. Full description at Econpapers || Download paper | 2 |
| 17 | 2015 | Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660. Full description at Econpapers || Download paper | 2 |
| 18 | 2020 | Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?. (2020). Lorgelly, Paula ; Shah, K ; Hernandez-Villafuerte, K ; Herdman, M. In: Consulting Reports. RePEc:ohe:conrep:002249. Full description at Econpapers || Download paper | 2 |
| 19 | 2017 | Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784. Full description at Econpapers || Download paper | 1 |
| 20 | 2019 | Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108. Full description at Econpapers || Download paper | 1 |
| 21 | 2021 | Realising The Broader Value of Vaccines in the UK: Ready for Prime Time?. (2021). Brassel, Simon ; Steuten, L ; Neri, M. In: Consulting Reports. RePEc:ohe:conrep:002322. Full description at Econpapers || Download paper | 1 |
| 22 | 2020 | Opportunities to Increase Efficiency in Healthcare. (2020). Hofmarcher, Thomas ; Zamora, B ; Skedgel, C ; Errea, M ; Cookson, G ; Lindgren, P. In: Consulting Reports. RePEc:ohe:conrep:002268. Full description at Econpapers || Download paper | 1 |
| 23 | Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation. (2018). Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002096. Full description at Econpapers || Download paper | 1 | |
| 24 | 2021 | Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. (2021). Lothgren, M ; Towse, A ; Bruce, A ; Steuten, L. In: Consulting Reports. RePEc:ohe:conrep:002320. Full description at Econpapers || Download paper | 1 |
| 25 | Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market. (2017). Lorgelly, Paula ; Hampson, Grace ; Berdud, Mikel ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001933. Full description at Econpapers || Download paper | 1 | |
| 26 | 2018 | A Critique of the Paper The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List. (2018). Shaw, B ; Hernandez-Villafuerte, K ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002015. Full description at Econpapers || Download paper | 1 |
| 27 | 2017 | Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries. (2017). Zamora, Bernarda ; Garau, Martina ; Mestre-Ferrandiz, J ; O'Neill, P ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001818. Full description at Econpapers || Download paper | 1 |
| 28 | 2015 | Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cole, Amanda ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001595. Full description at Econpapers || Download paper | 1 |
| 29 | 2020 | Realising the Broader Value of Vaccines in the UK. (2020). Brassel, Simon ; Steuten, L ; O'Neill, P ; Neri, M. In: Consulting Reports. RePEc:ohe:conrep:002282. Full description at Econpapers || Download paper | 1 |
| 30 | 2010 | Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe. (2010). Towse, Adrian ; Puig-Peiro, R ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000212. Full description at Econpapers || Download paper | 1 |
50 most relevant documents in this series (papers most cited in the last two years)
| # | Year | Title | Cited |
|---|---|---|---|
| 1 | 2020 | International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making. (2020). Zhang, Kyann ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:002271. Full description at Econpapers || Download paper | 4 |
| 2 | 2018 | Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. (2018). Towse, Adrian ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:001978. Full description at Econpapers || Download paper | 2 |
| 3 | 2018 | Barriers to Uptake of Minimal Access Surgery in the United Kingdom. (2018). Sampson, Christopher ; Lorgelly, Paula ; Cole, Amanda ; O'Neill, P. In: Consulting Reports. RePEc:ohe:conrep:001976. Full description at Econpapers || Download paper | 2 |
| 4 | 2020 | A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold. (2020). , Towse ; FERRARO, . In: Consulting Reports. RePEc:ohe:conrep:002284. Full description at Econpapers || Download paper | 2 |
Citing documents used to
compute impact factor: 2
| Year | Title | |
|---|---|---|
| 2023 | Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe. (2023). Mestre-Ferrandiz, Jorge ; Indra, Peter ; Harney, Mary ; Felix, Jorge ; Espin, Jaime ; Barham, Leela ; Danko, David ; Wilking, Nils ; Henshall, Christopher H ; Vonina, Luka ; Spandonaro, Federico ; Pouvourville, Gerard. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:4:d:10.1007_s40258-023-00795-8. Full description at Econpapers || Download Value assessment of antimicrobials using the STEDI framework â How steady is the outcome?. (2023). Steuten, Lotte ; al Taie, Amer ; Brassel, Simon. In: Health Policy. RePEc:eee:hepoli:v:136:y:2023:i:c:s016885102300177x. Full description at Econpapers || Download paper |
Recent citations
Recent citations received in 2021
| Year | Citing document |
|---|